Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

The value of Afrezza will be based on the label that the F.D.A. allows, any additional REMS, and whether or not periodic lung function tests are required.

This is why Mannkind hasn't been able to find a marketing partner for Afrezza.

Would you pay $25,000 for a car if you didn't know the year of the car, the make, the model, or the condition of the car?

It reminds me of Gerald's comment in regards to the value of a LymPro partnership, "Someone may offer you "X" today when in three months they'll offer you 200 times "X"."

It's been more than three months and I'm expecting more than 200 times.

Overdue for news especially a Chairman's blog.

Twitter: @AmarantusBio .... 10,000 followers.